CFDA#

None
|
|
Funder Type

Corporate Foundation
|
IT Classification

B - Readily funds technology as part of an award
|
|
|
Authority

American Lung Association
Summary

For over 115 years the American Lung Association has focused on driving excellence and innovation through research. Today, we continue to support trailblazing research, novel ideas and innovative approaches with the hope of eliminating lung disease and improving life for those living with lung disease. Together, we are investing in brilliant scientific minds of the future and supporting projects with the potential to improve prevention, detection and treatment options. Through the lens of scientific innovation, pioneering new ideas, the American Lung Association is championing the next generation of brilliant scientists to independence and beyond.
History of Funding

None is available.
Additional Information

Current Funding Opportunities:
COVID-19 & Respiratory Virus Research Award: $100,000 per year for up to two years
This award is intended to support investigators who have the ability to advance our knowledge of COVID-19 and other novel respiratory viruses with pandemic potential. Successful applicants have evidence of ongoing excellence and productivity in a related field. A Letter of Intent (LOI) is required for this award. LOI due September 23, 2021.
Lung Cancer Discovery Award: $100,000 per year for up to two years
Intended to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods. A Letter of Intent (LOI) is required for this award. LOI due September 23, 2021.
ALA/ATS/CHEST Foundation Respiratory Health Equity Research Award: $100,000 per year for up to two years
A new joint effort between the American Lung Association, ATS and the CHEST Foundation supports clinical research to improve outcomes in preventing and/or treating lung diseases that disproportionately affect under-represented minority patient groups. The effort will support two $100,000 grants. One awarded grant is intended to support investigators that will address topics on improving clinical outcomes in preventing and/or treating lung disease in groups disproportionately impacted. The second awarded grant is intended to support an investigator who is a person of color that is doing clinical research in a pulmonary disease that disproportionately affects communities of color. A Letter of Intent is required for this award and is due September 14, 2021.
Allergic Respiratory Diseases Award: $75,000 per year for up to two years
A long-standing joint effort between the American Lung Association and the American Academy of Allergy, Asthma & Immunology to encourage and support early-stage investigators with a primary faculty appointment in an allergy/immunology division or section, to conduct research into advancing the understanding of allergic respiratory disease. Applications are due by December 16, 2021.
Innovation Award: $75,000 per year for up to two years
This award will support promising independent investigators who are leveraging their existing body of work to conduct basic science, behavioral, clinical, or translational research for lung health. Applications are due by December 16, 2021.
Catalyst Award: $50,000 per year for up to two years
This award champions the next generation of scientists who are ascending toward independence by supporting mentored-investigators who are conducting basic science, behavioral, clinical or translational research into lung health. Applications are due by December 16, 2021.
Public Policy Research Award: $50,000 per year for up to two years
This mechanism is designed to help stimulate and inform important public policy debates around healthy air and lung disease. This award supports research on and evaluation of existing public policy and programs, as well as projects that inject innovative ideas into public policies impacting lung health. Applications are due by December 16, 2021.
Dalsemer Award: $50,000 per year for up to two years
This is a mentored award meant to provide seed monies to junior investigators for researching the mechanisms and biology of interstitial lung disease. Applications are due by December 16, 2021.
Previous Funding Opportunities:
Lung Cancer Discovery Award: Intended to support independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our current understanding of lung cancer and improving diagnostic, clinical and treatment methods. A Letter of Intent (LOI) is required for this award.
Allergic Respiratory Diseases Award: A long-standing joint effort between the American Lung Association and the American Academy of Allergy, Asthma & Immunology to encourage and support early-stage investigators with a primary faculty appointment in an allergy/immunology division or section, to conduct research into advancing the understanding of allergic respiratory disease.
Innovation Award: This award will support promising independent investigators who are leveraging their existing body of work to conduct basic science, behavioral, clinical, or translational research for lung health.
Catalyst Award: This award champions the next generation of scientists who are ascending toward independence by supporting mentored-investigators who are conducting basic science, behavioral, clinical or translational research into lung health.
Public Policy Research Award: This mechanism is designed to help stimulate and inform important public policy debates around healthy air and lung disease. This award supports research on and evaluation of existing public policy and programs, as well as projects that inject innovative ideas into public policies impacting lung health.
Dalsemer Award: This is a mentored award meant to provide seed monies to junior investigators for researching the mechanisms and biology of interstitial lung disease.
Eligibility Details

While eligibility varies by award type, the following requirements apply to all awards:
- Candidates must be U.S. citizens or foreign nationals holding one of the following visa immigration statuses:
- permanent resident (Green Card),
- exchange visitor (J-1),
- temporary worker in a specialty occupation (H-1B),
- Canadian or Mexican citizen engaging in professional activities (TN),
- Australians in Specialty Occupation (E-3 visa)
- temporary worker with extraordinary abilities in the sciences (O-1)
- Candidates must be employed by a U.S. not-for-profit institution.
- Candidates are only allowed to submit 1 application per review cycle. Applicants who apply for more than one grant or award will forfeit any chance of funding.
Deadline Details

Deadlines vary by program:
- October 3, 2019: Lung Cancer Discovery Award Letters of Intent Due
- December 12, 2019: Applications due for the Catalyst Award; Dalsemer Award; Respiratory Diseases Award; Public Policy Award; and Innovation Award.
- January 23, 2020: Lung Cancer Discovery Award proposals due (invitation only)
Award Details

Award amounts vary based on program:
COVID-19 & Respiratory Virus Research Award: $100,000 per year for up to two years
Lung Cancer Discovery Award: $100,000 per year for up to two years
ALA/ATS/CHEST Foundation Respiratory Health Equity Research Award: $100,000 per year for up to two years
Allergic Respiratory Diseases Award: $75,000 per year for up to two years
Innovation Award: $75,000 per year for up to two years
Catalyst Award: $50,000 per year for up to two years
Public Policy Research Award: $50,000 per year for up to two years
Dalsemer Award: $50,000 per year for up to two years
Related Webcasts
-
Funding Classroom Technology to Empower Students and Teachers - Sponsored by Panasonic
-
Playback Available
-
Maximizing Technology-friendly Workforce Development Grants - Sponsored by Panasonic
-
Playback Available
-
Funding Data-driven Workforce Development Projects - Sponsored by NetApp
-
Playback Available